A siRNA targets and inhibits a broad range of SARS‐CoV‐2 infections including Delta variant-Reference-Cited by-同舟云学术

A siRNA targets and inhibits a broad range of SARS‐CoV‐2 infections including Delta variant

Published:2022-02-21 Issue:4 Volume:14 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Chang Yi‐Chung¹,Yang Chi‐Fan²,Chen Yi‐Fen¹,Yang Chia‐Chun²^ORCID,Chou Yuan‐Lin²,Chou Hung‐Wen¹,Chang Tein‐Yao³,Chao Tai‐Ling⁴,Hsu Shu‐Chen³,Ieong Si‐Man⁴,Tsai Ya‐Min⁴^ORCID,Liu Ping‐Cheng³,Chin Yuan‐Fan³,Fang Jun‐Tung⁴,Kao Han‐Chieh⁴,Lu Hsuan‐Ying³,Chang Jia‐Yu³,Weng Ren‐Shiuan¹,Tu Qian‐Wen¹,Chang Fang‐Yu¹,Huang Kuo‐Yen⁵,Lee Tong‐Young²,Chang Sui‐Yuan⁴⁶^ORCID,Yang Pan‐Chyr⁷⁸⁹^ORCID

Affiliation:

1. Oneness Biotech Company Limited Taipei Taiwan

2. Microbio (Shanghai) Biotech Company Shanghai China

3. Institute of Preventive Medicine National Defense Medical Center Taipei Taiwan

4. Department of Clinical Laboratory Sciences and Medical Biotechnology National Taiwan University College of Medicine Taipei Taiwan

5. Institute of Microbiology and Immunology National Defense Medical Center Taipei Taiwan

6. Department of Laboratory Medicine National Taiwan University Hospital and National Taiwan University College of Medicine Taipei Taiwan

7. Department of Internal Medicine National Taiwan University Hospital and National Taiwan University College of Medicine Taipei Taiwan

8. Genomics Research Center Academia Sinica Taipei Taiwan

9. Institute of Biomedical Sciences Academia Sinica Taipei Taiwan

Funder

Ministry of Science and Technology, Taiwan

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202115298

Reference53 articles.

1. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

2. Inhibition of respiratory viruses by nasally administered siRNA

3. Gene essentiality and synthetic lethality in haploid human cells

4. Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates

5. Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the effect of RNA secondary structure on Cas13d-mediated target RNA cleavage;Molecular Therapy - Nucleic Acids;2024-09

2. Flexible nano-liposomes-encapsulated recombinant UL8-siRNA (r/si-UL8) based on bioengineering strategy inhibits herpes simplex virus-1 infection;Antiviral Research;2024-08

3. Lung-targeted delivery of nsp12 siRNAs restores host type I interferon responses;Chemical Engineering Journal;2024-07

4. Development of a highly stable, active small interfering RNA with broad activity against SARS-CoV viruses;Antiviral Research;2024-06

5. BERT-siRNA: siRNA target prediction based on BERT pre-trained interpretable model;Gene;2024-06